Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01656447

Scleroderma Registry & Repository at the Hospital for Special Surgery

The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS). The registry facilitates our understanding of the clinical features, pathobiology, genetics of Scleroderma. This will ultimately lead to a potential treatment for this currently untreatable condition.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital for Special Surgery

New York, 10021, United States

Location status: Recruiting

Location contact

Eliza Pelrine, BA

CONTACT

[email protected]

212-774-2123

Jessica Gordon, MD

SUB_INVESTIGATOR

Robert Spiera, MD

PRINCIPAL_INVESTIGATOR

About this study

What will be asked of you:

  • Completion of 2 health questionnaires
  • Donation of research bloods. This is optional, but encouraged (if possible).
  • We also encourage patients who come for initial visits to return so follow-up data can be collected.

Benefits to Patients:

  • The HSS Scleroderma Registry gives patients the opportunity to participate in observational research with the goal of improving the lives of patients in the future.
  • By donating research bloods and providing clinical information, patients will help generate new knowledge about Scleroderma that can guide the treatment and care of patients afflicted with this rare disease.
  • Patients will also receive a comprehensive, medical evaluation from an HSS physician who specializes in treating Scleroderma. He or she will provide guidance on treatment options and recommendations for current or upcoming clinical trials.
  • Physicians will also make patients aware of the resources available to them, including support groups and educational programs.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals older than 18 years of age with Scleroderma

Exclusion criteria

  • Individuals younger than 18 years of age
  • Individuals older than 18 years of age without Scleroderma

Treatment and study plan

Primary outcomes

  1. Modified Rodnan Skin Score

    Time frame: Baseline & follow-up visits during regularly scheduled appointments for up to 5 years

    Physician score of skin thickening over 17 areas of the body.

Secondary outcomes

  1. Scleroderma Health Assessment Questionnaire

    Time frame: Baseline & follow-up visits during regularly scheduled appointments for up to 5 years

    Patient questionnaire

  2. Short Form-36

    Time frame: Baseline & follow-up visits during regularly scheduled appointments for up to 5 years

    Patient questionnaire

Study contacts

Contact information is provided by the study sponsor or research team.

Eliza Pelrine, BA

CONTACT

[email protected]

(212)774-2123

Emily Bakaj, BA

CONTACT

[email protected]

(212)774-7620

Sponsors and collaborators

Lead sponsor

Hospital for Special Surgery, New York

Other

Registry information

Official study title

The Scleroderma Registry & Repository

Important dates

Study start
2006
Primary completion
2030
Study completion
2030
First posted
Aug 3, 2012
Registry last updated
Nov 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.